MALIGNANT NEOPLASM PROGRESSION

This adverse event was reported 63327 times

These drugs are most commonly taken by patients reporting MALIGNANT NEOPLASM PROGRESSION:

# Drug Count
0 NIVOLUMAB 7250
1 ENZALUTAMIDE 4575
2 PEMBROLIZUMAB 4564
3 EVEROLIMUS 3795
4 CARBOPLATIN 3021
5 DEXAMETHASONE 2745
6 CAPECITABINE 2651
7 IPILIMUMAB 2619
8 LETROZOLE 2381
9 FULVESTRANT 2281
See all common drugs associated with MALIGNANT NEOPLASM PROGRESSION

MALIGNANT NEOPLASM PROGRESSION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFATINIB 1456 0.2695
1 CERITINIB 368 0.1909
2 GEFITINIB 1468 0.1870
3 PRALATREXATE 76 0.1652
4 RUCAPARIB 1009 0.1555
5 OLAPARIB 1104 0.1485
6 RAMUCIRUMAB 568 0.1445
7 PEMBROLIZUMAB 4564 0.1425
8 OSIMERTINIB 1506 0.1322
9 STREPTOZOCIN 18 0.1295
See all drugs enriched for association with MALIGNANT NEOPLASM PROGRESSION